Neurobo Pharmaceuticals Stock Target Price and Analyst Consensus
| NRBO Stock | USD 2.36 0.01 0.43% |
The current analyst and expert consensus on Neurobo Pharmaceuticals is Strong Buy, with only one strong buy opinion. The current projected Neurobo Pharmaceuticals target price consensus is 6.00 with 2 analyst opinions. Check out Macroaxis Advice on Neurobo Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Neurobo Stock, please use our How to Invest in Neurobo Pharmaceuticals guide.The most common way Neurobo Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Neurobo Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Neurobo Pharmaceuticals. We encourage you to use your own analysis of Neurobo Pharmaceuticals to validate this buy or sell advice. Neurobo Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Neurobo Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 4.8531.
Lowest Forecast 5.46 | Highest Forecast 6.66 | Target Price 6 |
Neurobo |
It's important to approach Neurobo Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Neurobo Pharmaceuticals price targets
Neurobo Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Neurobo Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Neurobo Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Neurobo Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Neurobo Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Neurobo Pharmaceuticals is a key component of Neurobo Pharmaceuticals valuation and have some predictive power on the future returns of a Neurobo Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | Investor Favorites Invested over 40 shares | |
 | Hedge Favorites Invested over 40 shares | |
 | Cash Cows Invested few shares | |
 | Manufacturing Invested over 30 shares | |
 | Business Services Invested over 100 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Adviser Favorites Invested few shares | |
 | Impulse Invested over 100 shares | |
 | Momentum Invested few shares | |
Check out Macroaxis Advice on Neurobo Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Neurobo Stock, please use our How to Invest in Neurobo Pharmaceuticals guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.